% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

  • golongin2008 golongin2008 Aug 20, 2010 8:59 PM Flag

    ML Lowers Price Target to $14

    Their report says a very recent change in the trials end point and protocol to add an easier objective may give an advantage to placebo and make the trials endpoint actually statistically harder to achieve. That and forseeable competition from another company (starts with an "S") with a similar product entering Phase III could limit upside NT even with good results.

    Says trial risks are now increased. 50% decline if results do not meet stat significance so more cautious... Still maintain longer term buy opinion though.

    Comments anyone?

15.72-0.15(-0.95%)Sep 23 4:00 PMEDT